context hepatitis b vaccination of hemodialysis patients is performed all over the world. there are also recommendations from world health organizations to vaccinate patients with chronic kidney disease (ckd) prior dialysis commencement, but the implementation of a hepatitis b vaccination program is less common and not well organized. evidence acquisition this review article summarizes data ind...

Four hundred and fifty three healthy children immunized with a course of hepatitis B vaccine beginning at birth were tested at 10-11 years of age for persistence of anti-hepatitis B-S antigen antibody (anti-HBs); and responses of children without protective antibody to different doses of hepatitis B vaccine booster were evaluated. Although nearly 42% of them were not seroprotected, but most of ...

background & objectives: hepatitis b is one of the major health problems in the world. health care workers (hcws) are at high risk of acquiring hepatitis b virus. the aim of this study was to evaluate the prevalence of hbv infection and the immune response to hbv vaccine among the hcws in babol, northern iran. methods: this study was accomplished on 527 hcws and administrative staff working...

BACKGROUND Hepatitis B vaccine and hepatitis B immunoglobulin are considered for newborn infants of HBsAg-positive mothers to prevent hepatitis B infection. OBJECTIVES To assess the beneficial and harmful effects of hepatitis B vaccines and hepatitis B immunoglobulin in newborn infants of HBsAg-positive mothers. SEARCH STRATEGY Trials were identified through The Cochrane Neonatal Group Cont...

The hepatitis B vaccine is considered to be highly immunogenic and has a good safety profile. In adults, it has a primary non-response rate of 5%-10%. Causes of nonresponse to hepatitis B vaccine include age, sex, obesity smoking. Certain human leucocyte antigen (HLA) phenotypes have been known to be associated with responsiveness to the vaccine, and found to be different in different ethnic gr...

The recent addition of testing volunteer blood donors for antibody to hepatitis B core antigen (anti-HBc) has raised questions not apparent when such testing is applied to hepatitis B (HB) infected patients. The review of published studies, and our own, demonstrates that it is difficult to evaluate false positive results. Some patients appear to lose antibody to hepatitis B surface antigen (ant...

Objective: To compare immunogenicity of a recombinant hepatitis B (HB) vaccine in two groups of neonates born in two cities of Iran with different geographic and ethnic backgrounds.   Materials and Methods: Ten micrograms of a recombinant HB vaccine was administered under field condition to Iranian healthy neonates at 0, 1.5 and 9 months intervals. The subjects consisted of two groups of 290 an...

OBJECTIVES This study aimed to evaluate the level of hepatitis B immunity among undergraduate students 23 years after commencement of the nationwide hepatitis B childhood immunization program in Malaysia. METHODS A total of 402 serum samples obtained from volunteer undergraduate students were screened for the presence of hepatitis B surface antibodies using qualitative ELISA. RESULTS Result...

OBJECTIVE The aim of this study was to assess the antibody response to combined passive-active immunization versus active immunization against hepatitis B in 71 patients with acute leukemia with negative hepatitis B virus serology at presentation. METHODS The first group (n=28) received a double dose of hepatitis B vaccine at 0, 1, 2 and 6 months and immunoglobin (HBIG) at 0 and 1 month concu...

Compliance with and responses to the hepatitis B vaccine were evaluated in remaining quilombo communities in Central Brazil. A total of 708 individuals who were susceptible to hepatitis B virus infection were invited to participate in the hepatitis B vaccination program in eight communities. Although 567 (80%) individuals received the first dose, only 198 (28%) complied with the full vaccinatio...